Sophie V. Vandebroek Idexx Laboratories Inc (IDXX) insider trading activity

Sophie V. Vandebroek is Director of IDEXX LABORATORIES INC . Currently has a direct ownership of 1,167 shares of IDXX, which is worth approximately $607,528. The most recent transaction as insider was on May 09, 2025, when has been sold 1,279 shares (Common Stock) at a price of $491.34 per share, resulting in proceeds of $628,423. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.17K

28.95% 3M change

20.77% 12M change

Total Value Held $607,528

Sophie V. Vandebroek Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 09 2025	SELL Open market or private sale	$628,423 $491.34 p/Share	1,279 Reduced 52.29%	1,167 Common Stock
May 09 2025	BUY Exercise of conversion of derivative security	$362,711 $283.59 p/Share	1,279 Added 34.34%	2,446 Common Stock
May 06 2025	BUY Exercise of conversion of derivative security	-	262 Added 18.33%	1,167 Common Stock
Nov 27 2024	SELL Open market or private sale	$144,631 $420.44 p/Share	344 Reduced 27.54%	905 Common Stock
Nov 27 2024	SELL Bona fide gift	-	224 Reduced 15.21%	1,249 Common Stock
May 06 2024	BUY Exercise of conversion of derivative security	-	257 Added 14.86%	1,473 Common Stock
Mar 05 2024	SELL Open market or private sale	$790,423 $562.98 p/Share	1,404 Reduced 53.59%	1,216 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	$345,089 $245.79 p/Share	1,404 Added 34.89%	2,620 Common Stock
May 11 2023	BUY Exercise of conversion of derivative security	-	344 Added 22.05%	1,216 Common Stock
May 04 2023	SELL Open market or private sale	$1,025,746 $469.02 p/Share	2,187 Reduced 71.49%	872 Common Stock
May 04 2023	BUY Exercise of conversion of derivative security	$451,877 $206.62 p/Share	2,187 Added 41.69%	3,059 Common Stock
May 11 2022	BUY Exercise of conversion of derivative security	-	224 Added 20.44%	872 Common Stock
Feb 12 2021	SELL Open market or private sale	$1,639,357 $538.2 p/Share	3,046 Reduced 47.84%	3,321 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	$488,213 $160.28 p/Share	3,046 Added 32.36%	6,367 Common Stock

Also insider at

PKI

PERKINELMER INC Healthcare

SVV